CoChat
Cited by 231

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Targeted Disruption of the Estrogen Receptor-α Gene in Female Mice: Characterization of Ovarian Responses and Phenotype in the Adult*

Schomberg, David W., Couse, John F., Mukherjee, Abir, Lubahn, Dennis B., Sar, M., Mayo, Kelly E., Korach, Kenneth S. · 1999 · Endocrinology

Abstract

Targeted disruption of the mouse estrogen receptor-alpha gene (estrogen receptor-alpha knockout; ERKO) results in a highly novel ovarian phenotype in the adult. The ERKO mouse model was used to characterize ER alpha-dependent processes in the ovary. Visualization of the ovaries of 10-, 20-, and 50-day-old wild-type (WT) and ERKO mice showed that the ERKO phenotype developed between 20 and 50 days of age. Developmental progression through the primordial, primary, and antral follicle stages appeared normal, but functional maturation of preovulatory follicles was arrested resulting in atresia or in anovulatory follicles, which in many cases formed large, hemorrhagic cysts. Corpora lutea were absent, which also indicates that the normal biochemical and mechanical processes that accomplish ovulation were compromised. Northern and ribonuclease protection analyses indicated that ERKO ovary FSH receptor (FSHR) messenger RNA (mRNA) expression was approximately 4-fold greater than in WT controls. Ovarian LH receptor (LHR) mRNA expression was also higher in the ERKO animals. Cellular localization studies by in situ hybridization analysis of ERKO ovaries showed a high level of LHR mRNA expression in the granulosa and thecal layers of virtually all the antral follicles. Ribonuclease protection analyses showed that ovarian progesterone receptor and androgen receptor mRNA expression were similar in the two groups. These results indicated that ER alpha action was not a prerequisite for LHR mRNA expression by thecal or granulosa cells or for ovarian expression of progesterone receptor mRNA. Ovarian estrogen receptor beta (ER beta) was detected immunohistochemically, was sharply compartmentalized to the granulosa cells, and was expressed approximately equally in the ERKO animals and the WT controls. In contrast, ER alpha staining was present in the thecal cells but not the granulosa cells of the WT animals. The summary findings indicate that in the adult the major cause of the ERKO phenotype is high circulating LH interacting with functional LHR of the theca and granulosa cells. These features result in a failure of the normal maturational events leading to successful ovulation and luteinization and presumably involve both hypothalamic-pituitary and intraovarian mechanisms dependent upon ER alpha action. The presence of ER beta in the granulosa cells did not rescue the phenotype of the ovary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endo.140.6.6823

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Clark, 1994, Actions of ovarian steroid hormones, 1011
  2. Richards, 1976, Protein hormone action: a key to understanding ovarian follicular and luteal cell development., Biol Reprod, 14, 82, 10.1095/biolreprod14.1.82 · DOI · Paper page
  3. Hurst, 1995, Estrogen receptors are present in human granulosa cells., J Clin Endocrinol Metab, 80, 229
  4. Goldenberg, 1972, Estrogen and follicle stimulating hormone interactions on follicle growth in rats., Endocrinology, 90, 1492, 10.1210/endo-90-6-1492 · DOI · Paper page
  5. Mulheron, 1992, Effects of diethylstilbestrol on rat granulosa cell and thecal/interstitial cell transforming growth factor-β2 mRNA expression in vivo: analysis by reverse transcription-polymerase chain reaction., Biol Reprod, 46, 546, 10.1095/biolreprod46.4.546 · doi:10.1095/biolreprod46.4.546
  6. Billig, 1993, Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis., Endocrinology, 133, 2204, 10.1210/endo.133.5.8404672 · doi:10.1210/endo.133.5.8404672 · Paper page
  7. Wiesen, 1993, Changes in expression of connexin 43 gap junction messenger ribonucleic acid and protein during ovarian follicular growth., Endocrinology, 133, 741, 10.1210/endo.133.2.8393773 · DOI
  8. Richards, 1980, Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation., Physiol Rev, 60, 51, 10.1152/physrev.1980.60.1.51 · DOI · Paper page
  9. Scully, 1997, Role of estrogen receptor α in the anterior pituitary gland., Mol Endocrinol, 11, 674
  10. Lubahn, 1993, Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene., Proc Natl Acad Sci USA, 90, 11162, 10.1073/pnas.90.23.11162 · DOI · Paper page
  11. Dukes, 1994, Effects of a non- steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones., J Endocrinol, 141, 335, 10.1677/joe.0.1410335 · DOI
  12. Luo, 1997, Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice., Int J Cancer, 73, 381, 10.1002/(SICI)1097-0215(19971104)73:3<381::AID-IJC13>3.0.CO;2-G · DOI
  13. Sourla, 1997, Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800., Endocrinology, 138, 5605, 10.1210/endo.138.12.5560 · DOI
  14. Kuiper, 1996, Cloning of a novel estrogen receptor expressed in rat prostate and ovary., Proc Natl Acad Sci USA, 93, 5925, 10.1073/pnas.93.12.5925 · DOI · Paper page
  15. Byers, 1997, Estrogen receptor-β mRNA expression in rat ovary: down-regulation by gonadotropins., Mol Endocrinol, 11, 172
  16. Couse, 1995, Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene., Mol Endocrinol, 9, 1441
  17. Mor, 1992, Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors., Endocrinology, 130, 3633, 10.1210/endo.130.6.1597160 · doi:10.1210/endo.130.6.1597160
  18. Sar, 1985, Application of avidin and biotin technique for the localization of estrogen receptor in target tissues using monoclonal antibodies, 43
  19. Park, 1991, Transient expression of progesterone receptor messenger RNA in ovarian granulosa cells after the preovulatory luteinizing hormone surge., Mol Endocrinol, 5, 967, 10.1210/mend-5-7-967 · DOI · Paper page
  20. Couse, 1998, Exploring the role of sex steroids through studies of receptor deficient mice., J Mol Med, 76, 497, 10.1007/s001090050244 · DOI
  21. LaPolt, 1992, Gonadotropin-induced up-and down-regulation of ovarian follicle-stimulating hormone (FSH) receptor gene expression in immature rats: effects of pregnant mare’s serum gonadotropin, human chorionic gonadotropin, and recombinant FSH., Endocrinology, 130, 1289
  22. Heckert, 1991, Expression of Follicle-stimulating Hormone receptor mRNA in rat testes and Sertoli cells., Mol Endocrinol, 5, 670, 10.1210/mend-5-5-670 · DOI · Paper page
  23. Segaloff, 1993, The lutropin/choriogonadotropin receptor . . . 4 years later., Endocr Rev, 14, 324
  24. Lindzey, 1997, Developmental and physiological effects of estrogen receptor gene disruption in mice., Trends Endocrinol Metab, 8, 137, 10.1016/S1043-2760(97)00007-6 · DOI
  25. Dong, 1996, Growth differentiation factor-9 is required during early ovarian folliculogenesis., Nature, 383, 531, 10.1038/383531a0 · DOI · Paper page
  26. Kumar, 1997, Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility., Nat Genet, 15, 201, 10.1038/ng0297-201 · DOI · Paper page
  27. Zhou, 1997, Insulin-like growth factor I regulates gonadotropin responsiveness in the murine ovary., Mol Endocrinol, 11, 1924, 10.1210/mend.11.13.0032 · doi:10.1210/mend.11.13.0032 · Paper page
  28. Sicinski, 1996, Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis., Nature, 384, 47, 10.1038/384470a0 · DOI · Paper page
  29. Lim, 1997, Multiple female reproductive failures in cyclooxygenase 2-deficient mice., Cell, 91, 197, 10.1016/S0092-8674(00)80402-X · DOI · Paper page
  30. Yoshizawa, 1997, Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hyperplasia and growth retardation after weaning., Nat Genet, 16, 391, 10.1038/ng0897-391 · DOI · Paper page
  31. Guo, 1998, Overexpression of mouse Follistatin causes reproductive defects in transgenic mice., Mol Endocrinol, 12, 96, 10.1210/mend.12.1.0053 · DOI · Paper page
  32. Alexander, 1997, Female infertility in mice lacking connexin 37., Nature, 385, 525, 10.1038/385525a0 · DOI · Paper page
  33. Lydon, 1995, Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities., Genes Dev, 9, 2266, 10.1101/gad.9.18.2266 · DOI · Paper page
  34. Shupnik, 1998, Gonadal hormone feedback on pituitary gonadotropin genes., Trends Endocrinol Metab, 7, 272, 10.1016/S1043-2760(96)00124-5 · DOI
  35. Wilson, 1998, Estrogen receptor-β messenger ribonucleic acid expression in the pituitary gland., Endocrinology, 139, 5151, 10.1210/endo.139.12.6354 · DOI
  36. Risma, 1995, Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors., Proc Natl Acad Sci USA, 92, 1322, 10.1073/pnas.92.5.1322 · DOI · Paper page
  37. Risma, 1997, Elevated LH in prepubertal transgenic mice causes hyperandrogenimia, precocious puberty, and substantial ovarian pathology., Endocrinology, 138, 3540, 10.1210/endo.138.8.5313 · DOI
  38. LaPolt, 1990, Gonadotropin- induced up- and down-regulation of rat ovarian LH receptor message levels during follicular growth, ovulation and luteinization., Endocrinology, 126, 3277, 10.1210/endo-126-6-3277 · doi:10.1210/endo-126-6-3277
  39. Piquette, 1991, Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells., Endocrinology, 128, 2449, 10.1210/endo-128-5-2449 · doi:10.1210/endo-128-5-2449
  40. Park-Sarge, 1994, Regulation of the progesterone receptor gene by gonadotropins and cyclic adenosine 3′,5′-monophosphate in rat granulosa cells., Endocrinology, 134, 709, 10.1210/endo.134.2.8299566 · DOI
  41. Clemens, 1998, Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: Evidence for a role of cyclic adenosine 3′5′-mono-phosphate but not estradiol., Mol Endocrinol, 12, 1201

Cited by

See all 231

Metadata

Authors
Schomberg, D. W., Couse, J. F., Mukherjee, A., Lubahn, D. B., Sar, M., Mayo, K. E., & Korach, K. S.
Venue
Endocrinology
Published
1999-06-01
Volume
140
Issue
6
Pages
2733-2744
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2170117373
Cited by
231
References
2
FWCI
13.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.